2014•SSRN Electronic JournalOpen access

Comment: First Amendment and Consumer Privacy Concerns in the Pharmaceutical Industry: Analyzing the Courts Protection on Commercial Speech Regarding Pharmaceutical Marketing, and How the Courts Have Expanded This Interpretation to Off Label Marketing and Pharmacy Compounding and the Results These Decisions Have on Consumer Privacy

Ronald Bakay

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Commercial speech, Pharmaceutical industry, Interpretation (philosophy), Pharmaceutical marketing, First amendment, Business, Marketing, Advertising

Back to paper search Browse research topics Original source

Comment: First Amendment and Consumer Privacy Concerns in the Pharmaceutical Industry: Analyzing the Courts Protection on Commercial Speech Regarding Pharmaceutical Marketing, and How the Courts Have Expanded This Interpretation to Off Label Marketing and Pharmacy Compounding and the Results These Decisions Have on Consumer Privacy — Research Paper | ScholarLens